Abstract
BackgroundLiberal oxygen therapy might increase the mortality rate of patients. Non-rebreathing masks (NRM) are a high-flow, non-invasive oxygen device that can provide oxygen concentration up to 95%. This study aimed to determine the impact of using NRM in patients with respiratory failure. MethodsThis retrospective cohort study was conducted in four medical institutions in Taiwan from January 2010 to December 2016. The association between mortality and NRM use before receiving ventilator support in patients with respiratory failure in the emergency department was analyzed. Patients were divided into the NRM treatment and no NRM treatment groups. A 1:4 propensity score matching was conducted. Regarding the duration of NRM use, treatments were grouped as 0 h, 0–1 h, 1–2 h, and >2 h. ResultsA total of 18,749 patients were included, with 1074 using NRM. After propensity score matching, 1028 patients using NRM (0–1 h: 508, 1–2 h: 193, and >2 h: 327) and 4112 patients not using NRM were analyzed. The 30-day mortality rates were 29.1%, 28.5%, 27.5%, and 35.5% in the 0 h, 0–1 h, 1–2 h, and >2 h treatment groups, respectively. Patients with respiratory failure due to pulmonary disease using NRM over 2 h had a higher mortality rate than patients not using NRM (hazard ratio: 1.3, 95% CI: 1.01–1.66). ConclusionsProlonged use of NRM in patients with respiratory failure due to pulmonary disease possibly increases mortality.
Highlights
Supplemental oxygen is a common therapy in clinical practice
Patients with respiratory failure due to pulmonary disease using Non-rebreathing mask (NRM) (> 2 hours) for a prolonged period had a higher mortality rate than patients not using NRM (OR: 1.4, 95% confidence intervals (CIs): 1.06–1.74)
Prolonged use of NRM (> 2 hours) in patients with respiratory failure due to pulmonary disease possibly results in an increased mortality rate
Summary
Supplemental oxygen is a common therapy in clinical practice. High-concentration oxygen therapy is commonly used in critically ill patients.[9,10] Non-rebreathing mask (NRM) is a relatively high-flow and non-invasive oxygen device that can provide oxygen concentration up to 95% under a continuous oxygen flow of 10–15 L/minute.[11] NRM is usually used to preoxygenate patients before induction and intubation[12,13,14] and is not used as a long-term oxygen therapy because it might result in carbon dioxide retention and nasal and oral mucosa irritation.[3]. Liberal oxygen therapy might increase the mortality rate of patients. Non-rebreathing mask (NRM) is a high-flow, non-invasive oxygen device that can provide oxygen concentration up to 95%. This study aimed to determine the impact of using NRM in patients with respiratory failure
Sign-in/Register to view highlights & summary 
Submitted Version (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call